FindTrial
Sign In

Comparison of efficacy and safety of fistula tract dilation between standard tapered cannulation catheter and coaxial electrocautery dilator in endoscopic ultrasound- guided hepaticogastrostomy: randomized controlled trial.

Comparison of efficacy and safety of fistula tract dilation between standard tapered cannulation catheter and coaxial electrocautery dilator in endoscopic ultrasound- guided hepaticogastrostomy: randomized controlled trial.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20210129004
Enrollment
50
Registered
2021-01-29
Start date
2021-02-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Biliary obstruction that require endoscopic ultrasound-guided hepaticogastrostomy for biliary drainage. Endoscopic ultrasound guided hepaticogastrostomy EUS HGS Biliary obstruction fistula dilator

Interventions

Use tapered tip catheter for dilate fistula tract between stomach and intrahepatic bile duct,Use electrocauterized dilator for dilate fistula tract between stomach and intrahepatic bile duct
Experimental Device,Active Comparator Device
Tapered tip dilator,Electrocauterized dilator

Sponsors

None listed

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Biliary obstruction which indicated for endoscopic ultrasound-guided hepaticogastrostomy Left intrahepatic duct larger than 5 millimeters Age more than 18 years

Exclusion criteria

Exclusion criteria: Uncorrectable coagulopathy Contrast material allergy Severe comorbidity Acute cholangitis with organ failure.

Design outcomes

Primary

MeasureTime frame
Fistula tract dilation at the end of the procedure Fistula tract dilation success rate—

Secondary

MeasureTime frame
Stent placement At the end of the procedure Stent placement success rate,Adverse events during procedure and 2 weeks after procedure Occur adverse event—

Countries

Thailand

Contacts

Public ContactThanawat Luangsukrerk

Faculty of Medicine, Chulalongkorn University

drthanawatl@gmail.com022564265

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026